The Second Infusion is live. Your infusion changed your life. Your second one changes hers.

Give the second infusion →

Our Model

Test. Diagnose.
Treat. Nine days.

A first-of-its-kind, scalable model to find and treat non-malignant blood disorders in women, built inside a network that already delivers the care. The Foundation pays for the parts insurance will not cover.

The journey

From a free test to iron in her arm.

Four steps, one team, no referral loop. The average from first consult to infusion is nine days. The national average from first symptom is measured in years.

01

Day 0

Screen

A free ferritin test at a workplace, school, club or community event. Results read by a hematology team, not left on a printout.

02

Within days

Consult

A board-certified hematologist sees her by video. Diagnosis, plan and prescription in one visit.

03

Nine days, on average

Treat

IV iron at a Fem center or brought to the community. About an hour in the chair.

04

After treatment

Follow up

Repeat labs, symptom check, and a plan for the next cycle or pregnancy. Nobody is discharged into silence.

Nine days: average televisit-to-infusion, ASH 2023, Abstract 2314. Diagnostic delay: Akpan et al., Women's Health, 2025

What we do

Four things, done properly.

01

Community screening

We bring the test to where women already are. Workplaces, schools, sports clubs, faith communities and public events across Miami-Dade and Broward. Ferritin, not just hemoglobin, so the depleted are found before they become anemic.

Free to the woman being tested

Results read by a hematology team

Bilingual intake, English and Spanish

02

Telemedicine hematology

Every abnormal result goes to a board-certified hematologist by video. No primary-care referral, no six-week wait, no specialist waiting room. Diagnosis and a treatment plan in one visit.

Board-certified hematology, by video

Led by Dr. Steven Fein, MD, MPH

Published at the American Society of Hematology

03

On-site and mobile treatment

IV iron delivered at Fem centers across South Florida, or brought to the community on screening days. The infusion takes about an hour. She goes back to work the same day.

Five treatment centers in Florida

Mobile treatment for screening events

4.5% reaction rate across 7,246 infusions

04

Direct funding

When insurance will not cover the test, the specialist or the treatment, the Foundation pays. Not a discount, not a payment plan. The full cost, so her coverage never decides her care.

Test, specialist and treatment covered

Published 40 / 20 / 20 / 10 / 10 allocation

Every gift tracked against it

The Fem Network

Built inside the system that already delivers the care.

Most foundations have to build a clinical partner from nothing. Fem Foundation sits inside the network that already runs the clinics, so every dollar goes to care rather than to standing up a care system.

Pays for the care

Fem Foundation

501(c)(3) nonprofit. Funds the test, the specialist and the treatment for women without coverage. Publishes the allocation.

Delivers the care

The clinics

Five treatment centers in Florida, telehealth-first. More than 5,000 women treated since 2020. Outcomes published at ASH.

Diagnoses and prescribes

The hematologists

Board-certified hematology by video. Led by Dr. Steven Fein, MD, MPH. Referral network across OB/GYN and hospitals.

Disclosure: Fem Foundation is the charitable arm of the Fem Network. The clinics and the hematology practice are separate organizations that deliver the clinical care the Foundation funds.

Published outcomes

The evidence behind the model.

Presented at the American Society of Hematology, the largest hematology meeting in the world. These are the clinic's numbers, and they are the reason the Foundation can promise nine days.

7,246

infusions across 3,076 patients in two years

ASH 2023, Abstract 2314

2,971

infusions to 1,383 pregnant patients

ASH 2023, Abstract 2381

9 days

average from televisit to infusion

ASH 2023, Abstract 2314

0

adverse events that affected a pregnancy

ASH 2023, Abstract 2381

94%

report improved symptoms after treatment

ASH 2023, Abstract 2314

1.2 g/dL

average hemoglobin rise in pregnancy

ASH 2023, Abstract 2381

Who it is for

Three ways in.

Women

Referred by your provider? Enroll in the Iron Planning Service and a navigator handles insurance, funding and scheduling for you.

Enroll now →

Employers

Free iron screening for your workforce. For every employee we test, your company funds treatment for a woman who cannot pay.

Bring it to your team →

Clinicians

Send the Fem Foundation enrollment link during the visit. Navigation starts when your patient submits it. If she cannot pay, the Foundation does.

Refer a patient →

Help us get her to nine days.

The model works. The only thing that decides whether a woman gets it is whether someone pays for it.

Sources

01

ASH 2023, Abstract 2314. Fem Network clinics: 7,246 infusions across 3,076 patients, nine-day average, 94% symptom improvement, 4.5% reaction rate.

02

ASH 2023, Abstract 2381. IV iron in pregnancy: 2,971 infusions to 1,383 patients, 1.2 g/dL average hemoglobin rise, no adverse pregnancy events.

03

Akpan I et al. Diagnostic delay in iron deficiency. Women's Health, 2025.

04

Fem Network clinical data. More than 5,000 women treated since 2020.

05

femfoundation.org. Published allocation of the $10M campaign.